BRIDGEWATER, NJ--Pharmaceutical company Hoechst Marion Roussel announced the opening of a $45 million drug innovation facility that it said will double the company's research capacity here. The 150,000-square-foot facility will house 200 researchers dedicated to lead generation functions, including analytical and medicinal chemistry, automated chemical synthesis, biotechnology, automated screening, and molecular modeling.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.